Ocumetics Technology Corp. (OTCFF)
USD 0.2
(0.0%)
USD 0.2
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.6 Million CAD | -62.44% |
| 2022 | -2.21 Million CAD | -271.11% |
| 2021 | -598.19 Thousand CAD | -246.81% |
| 2020 | -172.48 Thousand CAD | -382.75% |
| 2019 | -35.73 Thousand CAD | 52.96% |
| 2018 | -75.96 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -616.28 Thousand CAD | 13.75% |
| 2023 Q3 | -750.68 Thousand CAD | 49.57% |
| 2023 FY | -3.6 Million CAD | -62.44% |
| 2023 Q4 | -714.54 Thousand CAD | 4.81% |
| 2023 Q2 | -1.48 Million CAD | -123.74% |
| 2023 Q1 | -665.34 Thousand CAD | -22.57% |
| 2022 FY | -2.21 Million CAD | -271.11% |
| 2022 Q2 | -640.82 Thousand CAD | -24.83% |
| 2022 Q4 | -542.83 Thousand CAD | -6.28% |
| 2022 Q1 | -513.35 Thousand CAD | -4.93% |
| 2022 Q3 | -510.75 Thousand CAD | 20.3% |
| 2021 Q1 | -42.35 Thousand CAD | -238.26% |
| 2021 Q4 | -489.22 Thousand CAD | 0.0% |
| 2021 Q2 | -9650.00 CAD | 77.21% |
| 2021 FY | -598.19 Thousand CAD | -246.81% |
| 2020 Q1 | -21.84 Thousand CAD | 0.0% |
| 2020 Q3 | -102.46 Thousand CAD | 10.18% |
| 2020 Q2 | -114.07 Thousand CAD | -422.17% |
| 2020 Q4 | -12.52 Thousand CAD | 87.78% |
| 2020 FY | -172.48 Thousand CAD | -382.75% |
| 2019 FY | -35.73 Thousand CAD | 52.96% |
| 2018 FY | -75.96 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 409.734% |
| Ansell Limited | 129.3 Million USD | 102.789% |
| Ansell Limited | 129.3 Million USD | 102.789% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 111.581% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | -125.981% |
| Psykey, Inc. | -797.5 Thousand USD | -352.158% |
| ConvaTec Group Plc | 262.7 Million USD | 101.373% |
| ConvaTec Group Plc | 262.7 Million USD | 101.373% |
| Encision Inc. | -640.78 Thousand USD | -462.746% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -2442.825% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -3180.251% |
| Innovative MedTech Inc. | -4.27 Million USD | 15.631% |
| LifePoint, Inc. | -7.49 Million USD | 51.89% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 44.352% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 1192.721% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | -2834.315% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | -671.699% |
| SmileDirectClub, Inc. | -241.15 Million USD | 98.505% |
| Sector 10, Inc. | -39.84 Thousand USD | -8950.246% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 101.128% |
| SheerVision, Inc. | 155.72 Thousand USD | 2415.593% |
| United Health Products, Inc. | -2.42 Million USD | -48.606% |
| Vasamed, Inc. | 4.74 Million USD | 176.039% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | -57.182% |
| Yubo International Biotech Limited | -1.2 Million USD | -199.196% |